Manufacturers Life Insurance Company, The Aerie Pharmaceuticals Inc Transaction History

Manufacturers Life Insurance Company, The

$102 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 11, 2023	SELL	$6.37 - $15.23 $3,554 - $8,498	-558 Reduced 2.77%	19,618 $296,000
Q3 2022 Nov 03, 2022	SELL	$6.37 - $15.23 $3,554 - $8,498	-558 Reduced 2.77%	19,618 $297,000
Q2 2022 Aug 11, 2023	BUY	$4.95 - $9.16 $6,068 - $11,230	1,226 Added 6.47%	20,176 $151,000
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $6,068 - $11,230	1,226 Added 6.47%	20,176 $151,000
Q1 2022 Aug 11, 2023	BUY	$5.64 - $9.8 $106,878 - $185,710	18,950 New	18,950 $172,000
Q1 2022 May 20, 2022	SELL	$5.64 - $9.8 $28,983 - $50,362	-5,139 Reduced 21.33%	18,950 $172,000
Q4 2021 Feb 16, 2022	BUY	$7.02 - $13.33 $2,084 - $3,959	297 Added 1.25%	24,089 $169,000
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $13,617 - $20,005	-1,203 Reduced 4.81%	23,792 $271,000
Q2 2021 Aug 12, 2021	BUY	$15.16 - $18.97 $49,042 - $61,367	3,235 Added 14.87%	24,995 $400,000
Q1 2021 May 03, 2021	SELL	$13.12 - $20.9 $20,913 - $33,314	-1,594 Reduced 6.83%	21,760 $389,000
Q4 2020 Feb 12, 2021	BUY	$9.12 - $14.49 $8,180 - $12,997	897 Added 3.99%	23,354 $316,000
Q2 2020 Aug 10, 2020	SELL	$12.0 - $16.13 $58,476 - $78,601	-4,873 Reduced 17.83%	22,457 $335,000
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $21,690 - $46,752	1,832 Added 7.18%	27,330 $369,000
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $15,345 - $21,736	-866 Reduced 3.28%	25,498 $616,000
Q3 2019 Nov 12, 2019	SELL	$18.41 - $28.0 $533 - $812	-29 Reduced 0.11%	26,364 $536,000
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $87,315 - $145,304	3,014 Added 12.89%	26,393 $780,000
Q1 2019 May 13, 2019	BUY	$36.32 - $49.25 $64,250 - $87,123	1,769 Added 8.19%	23,379 $1.11 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $51,084 - $92,941	-1,548 Reduced 6.68%	21,610 $781,000
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $183,947 - $242,096	-3,276 Reduced 12.39%	23,158 $1.43 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $49,046 - $72,211	1,025 Added 4.03%	26,434 $1.79 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $6,649 - $7,930	130 Added 0.51%	25,409 $1.38 Million
Q4 2017 Feb 08, 2018	BUY	$50.85 - $65.1 $19,373 - $24,803	381 Added 1.53%	25,279 $1.51 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $1.21 Million - $1.5 Million	24,898	24,898 $1.21 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account